CYTOGENETIC STUDIES USING HPCM-STIMULATED SHORT-TERM LIQUID CULTURES OF CIRCULATING HEMOPOIETIC PRECURSOR CELLS IN PATIENTS WITH MYELOFIBROSISGANSER A; CARBONELL F.1982; BLUT; ISSN 0006-5242; DEU; DA. 1982; VOL. 44; NO 2; PP. 111-114; BIBL. 16 REF.Article

CYTOGENETIC STUDIES IN CHRONIC MYELOPROLIFERATIVE DISORDERS = ETUDES CYTOGENETIQUES DES MALADIES MYELOPROLIFERATIVES CHRONIQUESCARBONELL F; GANSER A; HEIMPEL H et al.1983; ACTA HAEMATOLOGICA; ISSN 0001-5792; CHE; DA. 1983; VOL. 69; NO 3; PP. 145-151; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

MODERN TRENDS IN HUMAN LEUKAEMIA V. WILSEDE, JUNE 20-24, 1982GANSER A; NOBIS P; PORZSOLT F et al.1982; BLUT; ISSN 0006-5242; DEU; DA. 1982; VOL. 45; NO 5; PP. 351-357Article

Evolving treatment options of myelodysplastic syndromesVERBEEK, W; GANSER, A.Annals of hematology (Print). 2001, Vol 80, Num 9, pp 499-509, issn 0939-5555Article

Megakaryocytic differentiation capacity of human pluripotent bone marrow progenitor cells CFU-GEMM in vivo after cryopreservationGANSER, A; HOELZER, D.Scandinavian journal of haematology. 1985, Vol 35, Num 4, pp 418-422, issn 0036-553XArticle

Treatment of myelodysplastic syndromes with hematopoietic growth factorsGANSER, A; HOELZER, D.Hematology/oncology clinics of North America. 1992, Vol 6, Num 3, pp 633-653, issn 0889-8588Article

THE FATE OF CELLS WITH CHROMOSOME ABERRATIONS AFTER TOTAL BODY IRRADIATION AND BONE MARROW TRANSPLANTATIONCARBONELL F; GANSER A; FLIEDNER TM et al.1983; RADIATION RESEARCH; ISSN 0033-7587; USA; DA. 1983; VOL. 93; NO 3; PP. 453-460; BIBL. 30 REF.Article

Growth kinetics of CFU-GEMM, BFU-E, and CFU-C in diffusion-chamber cultures of normal human bone marrow cellsGANSER, A; HOELZER, D.Experimental hematology. 1984, Vol 12, Num 9, pp 712-716, issn 0301-472XArticle

Clinical use of hematopoietic growth factors in the myelodysplastic syndromesGANSER, A; HOELZER, D.Seminars in hematology. 1996, Vol 33, Num 3, pp 186-195, issn 0037-1963Article

Evaluating the prognosis of patients with myelodysplastic syndromesAUL, C; GIAGOUNIDIS, A; GERMING, U et al.Annals of hematology (Print). 2002, Vol 81, Num 9, pp 485-497, issn 0939-5555, 13 p.Article

Presence of more than two rearranged immunoglobulin heavy-chain genes in adult precursor B-cell lymphoblastic leukemiaSCHARDT, C; HOELZER, D; GANSER, A et al.Annals of hematology (Print). 1992, Vol 64, Num 2, pp 72-77, issn 0939-5555Article

The interaction of mercurials with myelin: comparison of in vitro and in vivo effectsGANSER, A. L; KIRSCHNER, D. A.Neurotoxicology (Park Forest South). 1985, Vol 6, Num 1, pp 63-78, issn 0161-813XArticle

Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-α in a patient with malignant pleural mesotheliomaDUENSING, S; HAMM, H; GANSER, A et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 3, pp 141-142, issn 1084-9785Article

Treatment with growth factors in myelodysplastic syndromes : Les syndromes myélodysplasiques = Myelodysplastic syndromesGEISSLER, R. G; SCHULTE, P; GANSER, A et al.Pathologie et biologie. 1997, Vol 45, Num 8, pp 656-667, issn 0369-8114Conference Paper

Ganglioside localization on myelinated nerve fibres by cholera toxin bindingGANSER, A. L; KIRSCHNER, D. A; WILLINGER, M et al.Journal of neurocytology. 1983, Vol 12, Num 6, pp 921-938, issn 0300-4864Article

Interleukin-2 in hematology and oncology : state of the artPROBST, M; BUER, J; GANSER, A et al.The Cancer journal (Print). 1995, Vol 8, Num 5, pp 270-279, issn 0765-7846Article

Megakaryocytic cells in mixed haemopoietic colonies CFU-GEMM from the pheripheral blood of normal individualsGANSER, A; ELSTNER, E; HOELZER, D et al.British journal of haematology. 1985, Vol 59, Num 4, pp 627-633, issn 0007-1048Article

Differential expression of gangliosides on the surfaces of myelinated nerve fibersGANSER, A. L; KIRSCHNER, D. A.Journal of neuroscience research. 1984, Vol 12, Num 2-3, pp 245-255, issn 0360-4012Article

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cellsPINCHA, M; SALGUERO, G; BÜSCHE, G et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 8, pp 750-764, issn 0969-7128, 15 p.Article

Prognostic factors in allo-SCT of elderly patients with AMLKRAUTER, J; WAGNER, K; STADLER, M et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 4, pp 545-551, issn 0268-3369, 7 p.Article

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemiaHELL, G; HOELZER, D; SANZ, M. A et al.Leukemia. 2006, Vol 20, Num 3, pp 404-409, issn 0887-6924, 6 p.Article

Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver diseaseTACKE, F; SCHÖFFSKI, P; LUEDDE, T et al.Scandinavian journal of gastroenterology. 2004, Vol 39, Num 3, pp 259-266, issn 0036-5521, 8 p.Article

Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer: significant effect of food intake on the bioavailability of the oral camptothecin analogueSCHÖFFSKI, P; HERR, A; WANDERS, J et al.European journal of cancer (1990). 2002, Vol 38, Num 6, pp 807-813, issn 0959-8049Article

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantationEDER, M; BATTMER, K; KAFERT, S et al.Leukemia. 1999, Vol 13, Num 9, pp 1383-1389, issn 0887-6924Article

Page / 5